Abstract
Granulocyte-colony stimulating factor (G-CSF) is commonly used in bone marrow transplant donors to increase the number of circulating progenitor cells. G-CSF has also been studied following myocardial infarction, but concern has been raised about the risks of G-CSF administration in patients with coronary artery disease. We present two cases of ischemic cardiac complications that are likely to be related to administration of G-CSF and provide a contemporary overview of the literature on the cardiovascular risks of G-CSF.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 98-101 |
| Number of pages | 4 |
| Journal | Catheterization and Cardiovascular Interventions |
| Volume | 76 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 1 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Coronary artery disease
- Filgrastim/adverse effects
- Inflammation
- Myocardial infarction
Fingerprint
Dive into the research topics of 'Ischemic cardiac complications following G-CSF'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS